Inorganic Arsenic in Rice Cereals for Infants: Action Level; Draft Guidance for Industry; Supporting Document for Action Level for Inorganic Arsenic in Rice Cereals for Infants; Arsenic in Rice and Rice Products Risk Assessment: Report; Availability

Resumen

The Food and Drug Administration (FDA or we) is announcing the availability of a draft guidance for industry entitled "Inorganic Arsenic in Rice Cereals for Infants: Action Level," a supporting document entitled "Supporting Document for Action Level for Inorganic Arsenic in Rice Cereals for Infants" (the supporting document), and a risk assessment report entitled "Arsenic in Rice and Rice Products Risk Assessment: Report" (the risk assessment report). The draft guidance, when finalized, will identify for industry an action level for inorganic arsenic in rice cereals for infants that will help protect public health and is achievable with the use of current good manufacturing practice. It also will describe our intended sampling and enforcement approach. The risk assessment report includes a quantitative component (a mathematical model) that estimates occurrence of lung cancer and bladder cancer from long-term exposure to inorganic arsenic in rice and rice products, and a qualitative component that describes our review and evaluation of the scientific literature of certain non-cancer health risks, in certain susceptible life stages, from inorganic arsenic in rice and rice products.